Trulove, Susan2015-10-292015-10-292009-05-06http://hdl.handle.net/10919/62019Virginia Tech virologist Chris Roberts' goal is to develop a platform for a flu vaccine that allows rapid modifications to meet new strains of flu.text/htmlIn CopyrightResearchUniversity virologist developing more potent vaccine technology with applicability to many virusesPress releaseVirginia Tech. University Relations